Table 2.

Localization of angioedema (AE) attacks in the 57 patients over 1 year, compared to literature data for AE with FXII mutation 11 and AE with C1‐inhibitor (C1‐INH) deficiency from the French National Center of Reference for Angioedema (CREAK) database published in 2013 14

Sites	FXII‐HAE in this study	FXII‐HAE in the German study 11	C1‐INH‐HAE in the French study 14
Face	123 (38·1%)	1506 (37·0%)	39 (7%)
ENT	6 (1·9%)	167 (2·6%)	45 (8%)
Abdomen	88 (27·1%)	2267 (34·6%)	324 (57·1%)
Extremities	100 (31%)	2530 (62·2%)	241(42·5%)
Bladder	6 (1·9%)	27 (0·7%)	n.a.
Total of all attacks	323 (100%)	6547 (100%)	568 (100%)

ENT = ears, nose and throat; n.a. = not available.